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Abbreviations 
ADA – American Diabetes Association 
AF – Atrial Fibrillation 
ARIC – Atherosclerosis Risk in Communities 
BP – Blood Pressure 
CAC – Coronary Artery Calcium 
CHD – Coronary Heart Disease 
CI – Confidence Interval 
CV – Cardiovascular  
HDL – High-Density Lipoprotein 
HR – Hazard Ratio 
HTN – Hypertension  
LDL – Low-Density Lipoprotein 
MI – Myocardial Infarction 
NHIS – National Health Interview Surveys 
T2D – Type 2 Diabetes 
US – United States 
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Abstract 
 
A routine of light or moderate alcohol consumption (≤1 drink/day for women and 
1 to 2 drinks/day for men) were associated with a lower risk for all-cause 
mortality, coronary artery disease (CAD), type 2 diabetes mellitus (T2D), heart 
failure (HF), and stroke. Conversely, heavy drinking, (>4 drinks/day) is 
associated with an increased risk for death and cardiovascular (CV) disease 
(CVD). Excessive alcohol intake trails behind only smoking and obesity among 
the 3 leading causes of premature deaths in the United States (US). Heavy 
alcohol use is a common cause of reversible hypertension (HTN), nonischemic 
dilated cardiomyopathy, atrial fibrillation (AF), and stroke (both ischemic and 
hemorrhagic). Among males aged 15 to 59 years, alcohol abuse is perhaps the 
leading cause of premature death. As such, the risk-to-benefit ratio of drinking is 
less favorable in younger individuals. A daily habit of light to moderate drinking is 
ideal for those who choose to consume alcohol regularly. Red wine in particular 
before or during the evening meal is linked with the best long-term CV outcomes. 
Most of the studies on alcohol and health are observational, and correlation does 
not prove causation. Health care professionals should not advise nondrinkers to 
begin drinking because of the paucity of randomized outcome data coupled with 
the potential for alcohol abuse even among seemingly low risk individuals.  
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Introduction 
 
In Robert Louis Stevenson’s 1886 novel Dr. Henry Jekyll—a mild-mannered 
physician/healer drinks a potion that temporarily transforms him into an alter ego 
named Mr. Hyde—a homicidal sociopath.1 Alcohol’s association on health are 
analogous to the apocryphal Strange Case of Dr. Jekyll and Mr. Hyde. Prudent 
consumption of this dimorphic potion appears to improve cardiovascular (CV) 
health, but when consumed in excess, benefit transforms into detriment as 
alcohol unveils a deadly nature.  In common parlance ethanol is referred to as 
“alcohol”, and consumption of alcoholic beverages is known as “drinking”, which 
has been a custom in many cultures throughout recorded human history.2 
 
When alcohol assumes the malevolent Mr. Hyde identity, it is recognized 
as 1 of the 4 most common preventable and modifiable causes of major non-
communicable diseases.3 Excessive alcohol intake is responsible for 4% of all 
deaths, and it plays a causal role in 60 different diseases including atrial 
fibrillation (AF), stroke, hypertension (HTN), heart failure (HF), seizures, cirrhosis, 
poisonings, accidents, violence, and many malignancies including cancers of the 
larynx, colon, rectum, breast, and liver.4 Alcohol abuse also tends to harm the 
health and well-being of people around the drinker. The annual health care and 
economic costs related to alcohol are over $224 billion in the United States (US) 
alone.4,5 
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In stark contrast, when alcohol is consumed responsibly in light to 
moderate amounts it largely retains its benign Dr. Jekyll demeanor, and were 
associated with a lower risk for CV disease (CVD)—the leading cause of death in 
the US.6 Prudent habitual alcohol use also appears to be linked to lower risks for 
type 2 diabetes mellitus (T2D), stroke, HF, and all-cause mortality.4,7 
 
This review article will present the risks and benefits associated with 
alcohol consumption, outline the potential mechanisms of action whereby alcohol 
bestows benefits or induces harm, and suggest safe drinking practices, types 
and quantities of alcohol that optimize CV outcomes and minimize risk and 
detriment for those choosing to consume. The findings in this review were based 
on a literature search of PubMed for the 20-year period 1997 through 2017 using 
the search terms alcohol, ethanol, cardiovascular disease, coronary artery 
disease, heart failure, hypertension, stroke, and mortality. Studies were included 
in this review if they were judged to be methodologically sound, high quality, 
objective, and reproducible. 
 
US Adult Drinking Habits 
 
Among all US adults, about two-thirds report that they at least occasionally have 
a drink, and 44% drink regularly—defined as consuming at least 1 drink/week.8 
These regular drinkers imbibe a mean of 4.2 alcoholic drinks per week. While a 
similar proportion of men and women drink alcohol, men drinkers on average 
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ingest 6.2 alcoholic beverages/week, whereas women drinkers have a mean of 
2.2 drinks/week. Whites are more likely to drink alcohol than nonwhites, and on 
average, whites also tend to consume more drinks—4.5/week compared to 
3.3/week among nonwhites.8 Beer and wine are the favored drinks for men and 
women, respectively. Twenty percent of drinkers admit to occasional over-
consumption of alcohol, and this is a more common problem among males and 
younger individuals.8 
 
A standard drink, regardless of the variety, contains 13 to 14 grams of 
ethanol (0.6 fl oz of pure alcohol),9,10 which translates to 12 oz of beer (~5% 
ethanol), 5.5 oz of table wine (~12% ethanol), or 1.5 oz of distilled spirits or hard 
liquor (~40% ethanol).9,10 Alcohol intake can also be quantitated in units, 
whereby 1 unit equals 10 mL or 8 grams of ethanol, which corresponds to the 
amount of alcohol an average adult can metabolize in 1 hour. Thus, for example, 
25 mL of whiskey, or 6 oz of beer, or 3 oz of wine would each contain about 1 
unit of alcohol.9,10 
 
Epidemiological Studies 
 
The quantity and pattern of ethanol consumption largely determine the health 
effects of drinking.7 Epidemiological studies consistently find that light and 
moderate drinkers are observed to be at lower risk for CVD than nondrinkers, 
whereas heavy drinkers are at the highest risk. A meta-analysis comprising 1 
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million individuals found that light or moderate alcohol consumption was 
associated with highly significant reductions in mortality during follow up; 
maximum potential benefit noted at one-half to 1 drink daily for females (18% 
reduction in all-cause mortality; 99% CI, 13%-22%).11 Among males, maximal 
potential benefit was seen at 1 to 2 drinks/day, with an associated reduction of 
17% (95% CI, 15%-19%) in all-cause mortality. However, consumption in excess 
of 2.5 drinks/day in women and [>4 drinks/day in men was associated with 
proportionately higher death rates in a dose-dependent fashion (Fig 1). Another 
study evaluated one-quarter million US adults, finding that alcohol intakes of both 
light (≤3 drinks/week) and moderate (4-7 drinks/week for women, 4-14 
drinks/week for men) levels were associated with lower CVD mortality compared 
with either heavy users (>7 drinks/week in females or >14 drinks/week in males) 
or lifetime nondrinkers (Fig 2).12 
 
National Health Interview Surveys Study 
A scientifically impressive, statistically rigorous study from the National Health 
Interview Surveys (NHIS) examined the association between alcohol 
consumption and risk of mortality from all causes, and deaths specifically from 
cancer, and CVD.13 This study included 333,247 adults from the US and 
collected 2.7 million person-years of follow up data. Compared to lifetime 
abstainers, light drinkers (3 or less drinks/week) or moderate drinkers (>3-7 
drinks/week for women, and >3-14 drinks/week for men) were observed to have 
a lower risk of all-cause mortality (light—hazard ratio [HR]: 0.79; 95% confidence 
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interval [CI]: 0.76 to 0.82; moderate—HR: 0.78; 95% CI: 0.74 to 0.82). Lower 
risks for CVD were also observed for both light drinkers (HR: 0.74; 95% CI: 0.69 
to 0.80), and moderate drinkers (HR: 0.71; 95% CI: 0.64 to 0.78). However, 
heavy drinking (>14 drinks/week) was associated with elevated risks for all-cause 
mortality (HR: 1.11; 95% CI: 1.04 to 1.19) and cancer mortality (HR: 1.27; 95% 
CI: 1.13 to 1.42). Binge drinking (consuming ≥5 drinks during 1 day) at least 1 
day per week was also associated with significantly increased risks for both all-
cause mortality (HR: 1.13; 95% CI: 1.04 to 1.23) and cancer mortality (HR: 1.22; 
95% CI: 1.05 to 1.41). The maximal observed protection against both all-cause 
mortality (Fig 3) and CVD (Fig 4) was noted at approximately 7 to 9 drinks/week 
for both men and women. Furthermore, compared to never-drinkers, those who 
consumed up to 10 drinks/week were not observed to have an increased risk of 
cancer mortality (Fig 5).13  
The associated risk reductions of consuming light or moderate amounts of 
alcohol were most significant for older (≥60 years of age or older), and middle-
aged adults (40 to 59 years of age), but were less significant in younger adults 
(18 to 39 years of age), likely in part due to this younger cohort’s lower baseline 
risk of adverse health events such as coronary disease.13 Other large 
observational studies have also shown that the more favorable risk-benefit ratio 
of drinking is noted among the middle-aged and older cohorts as compared to 
younger individuals.14  
For younger individuals, baseline risks for CVD are very low and this 
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younger cohort is also more likely to engage in excessive and/or binge drinking 
and accordingly suffers a higher risk of alcohol-related accidents, violence, and 
poisoning.3-5 Thus, from a health and wellness perspective, the risks of drinking 
outweigh the benefits for many younger men and women.13 In contrast, middle-
aged and older individuals generally show more significant CVD risk reductions 
associated with light to moderate drinking.15 
 
Secondary Prevention 
 
Light and moderate drinking has also been shown to be associated with 
improved outcomes in individuals with established CVD. A meta-analysis of 8 
prospective studies comprising 16,351 patients with a previous diagnosis of CVD, 
the well-known J-shaped curve was again noted, with maximal observed risk 
reduction seen at ethanol intakes of about 26 grams/day (or about 2 drinks 
daily).16 Observational studies of patients with a myocardial infarction (MI) also 
have noted the familiar J-shaped relationship between alcohol intake and CVD 
events or mortality.17,18 A large prospective study of 45 US hospitals with a 
median follow-up of 4 years observed a lowered risk-adjusted post-MI, all-cause 
mortality rate among drinkers when compared with nondrinkers.19 Light to 
moderate habitual alcohol intake has also been associated with significantly less 
atherosclerotic progression in the grafts following coronary artery bypass 
surgery,20 and a lower prevalence of peripheral arterial disease and its 
complications.21-23 
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Arrhythmias 
 
Previous generations of physicians used the term “holiday heart” for the patients 
who presented with cardiac rhythm disturbances after excessive drinking.4 
Indeed binge drinking markedly increases risk of acute cardiac arrhythmias, most 
commonly AF.24,25 In the Copenhagen City Heart Study, alcohol intakes > 35 
drinks/week correlated with higher risk of AF in men.26 Above a benign threshold 
of approximately 1 drink/day, the relative risk of AF rises about 10% for each 
daily drink (Fig 6).27,28 
 
Excessive alcohol consumption, whether acutely in the form of binge 
drinking or due to heavy long-term drinking, can also trigger ventricular 
arrhythmias and rarely even sudden cardiac arrest.11,29 The proarrhythmic 
association of heavy alcohol consumption are likely due in part to its proclivity for 
QT interval prolongation and shortening of the atrial effective refractory period.30 
Acute alcohol intoxication and withdrawal both commonly are linked with 
hypomagnesemia and hypokalemia.31 Alcohol withdrawal also augments cardiac 
sympathetic activity and blunts both heart rate variability and baroreflex 
sensitivity— all of which are autonomic disturbances that predispose to cardiac 
arrhythmias.32 
 
Heart Failure 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
11 
 
 
In a large recent meta-analysis, light alcohol drinking (1 to 7 drinks/week) was 
inversely associated with risk of HF (RR, 0.86; 95% confidence interval, 0.81-
0.90). In this study, no statistically significant association was noted between 
moderate (7 to 14 drinks/week), high (14 to 28 drinks/week), or heavy (>28 
drinks/week) alcohol consumption and HF risk.33 Other studies also show that 
light to moderate alcohol consumption is associated with significantly reduced 
risk of HF,34 witnessed even among older individuals and HTN patients, albeit not 
due to a reduction in coronary heart disease (CHD).35-37 
 
Nevertheless, ethanol at higher doses is a well-documented cardiotoxin. 
Chronic heavy alcohol consumption can cause a specific cardiac condition 
known as alcoholic cardiomyopathy, which causes about one-third of all cases of 
nonischemic dilated cardiomyopathy in the US.38 Individuals who imbibe more 
than 90 grams/day of alcohol (>7 drinks/day) for at least 5 years, are at increased 
risk for developing alcoholic cardiomyopathy and HF. If a patient with alcoholic 
cardiomyopathy continues to drink, the 4-year mortality rate may be as high as 
50%; and this is a common cause of death among individuals who are chronic 
alcohol abusers.39 Crucially, abstinence from alcohol and treatment of HF 
dramatically improve both cardiac function and prognosis.38 
 
 
Alcohol and Blood Pressure (BP) 
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Regular alcohol consumption elevates BP in a dose-dependent fashion. 
Consumption in excess of 14 drinks/week independently increases risk of HTN, 
an association that has been noted in blacks, whites, Asians, and Hispanics.40,41 
Chronic heavy drinking is among the most common reversible causes of HTN, 
and heavy drinking causes about 16% of HTN cases worldwide.42 he American 
Society of Hypertension guidelines warn that intake of more than 2 alcoholic 
drinks/day increase BP.43 Above 2 drinks per day, each additional alcoholic drink 
will raise BP by about 1.5 mm Hg. Upon complete cessation of drinking, or with a 
substantial reduction of intake, the alcohol-induced HTN usually resolves within 2 
to 4 weeks. A multi-national meta-analysis showed a linear dose-response 
relationship between alcohol and BP whereby the relative risk for HTN was 1.7 
for 50 grams of ethanol/day (about 4 drinks/day) and 2.5 at 100 grams/day (8 
drinks/day).41 Importantly, 1 or 2 drinks consumed once daily in conjunction with 
a meal has a neutral effect on long term BP.44 
 
Alcohol and Stroke 
 
Chronic heavy alcohol intake and chronic alcoholism are potent independent risk 
factors for stroke.45-47 Yet even for this outcome, most studies report a J-shaped 
curve for the relationship between alcohol and ischemic stroke. As noted in other 
realms, a modest observed risk reduction was seen among light to moderate 
drinking, on the other hand heavy drinking was significantly associated with an 
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increased risk of stroke (Fig 7).48-50 A study of approximately 50,000 Japanese 
women followed for a mean of 17 years found that drinking more 300 
grams/week of ethanol (over 21 drinks/week) doubled the risk of stroke (a 
composite of both ischemic and hemorrhagic stroke).51 A recent meta-analysis of 
27 prospective studies reported that light and moderate alcohol intakes were 
associated with lower risk of ischemic stroke, whereas heavy drinking was 
associated with an increased risk of both ischemic and hemorrhagic strokes (Fig 
7).52 The American Stroke Association guidelines advise that heavy drinkers who 
have suffered an ischemic stroke or transient ischemic attack should eliminate or 
reduce their alcohol consumption. These guidelines also defined “reasonable” 
alcohol intake as not more than 2 drinks/day for males and 1 drink/day for 
females.53 
 
Alcohol and Diabetes 
Light or moderate alcohol intake is associated with a lower risk of developing 
CHD and its complications in the setting of T2D.54 Furthermore, a large body of 
evidence indicates that for non-T2D individuals, light or moderate drinking is 
associated with a significant decrease in risk of developing new T2D.55-57 With a 
mean of 12 years of follow-up, the Physicians’ Health Study found that light or 
moderate alcohol consumption was associated with a lowered risk of T2D.58 
However, heavy drinking (≥4 drinks/day) was not associated with reduced risk of 
new-onset T2D.59 A recent comprehensive meta-analysis on this topic found that 
various alcohol-containing beverages had differing effects on risk reduction of 
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T2D.60 Whereas wine was associated with a highly significant protection against 
new T2D, beer or spirits were associated with only slight reductions in T2D (Fig 
8).  The J-shaped alcohol relationship is also present for metabolic syndrome,61 
wherein a lower prevalence of metabolic syndrome is noted among individuals 
who are light or moderate drinkers.62 These results were reproduced in a cohort 
of older Italians63 and were also corroborated by a meta-analysis showing 
beneficial metabolic changes for ethanol intakes of <20 grams/day in women and 
<40 grams/day for men.64 The American Diabetes Association recommends 
limiting alcohol intake to not more than 2 drinks/day for diabetic males and not 
more than 1 drink/day for diabetic women.65 
 
How Moderate Drinking Might Reduce CV Risk 
 
It is the ethanol, not any other compound present in alcoholic beverages, that is 
the main driver of the potential health benefits at low and moderate doses of 
alcohol and the toxic effects at high doses.66,67 As mentioned above, light to 
moderate alcohol intake may augment insulin sensitivity, raise high-density 
lipoprotein (HDL) cholesterol, dampen inflammation, raise adiponectin, and 
improve endothelial function.66,68,69 Ethanol in a dose-dependent fashion raises 
HDL (particularly the cardioprotective HDL2 subfraction) and apolipoprotein A-I.70 
A linear correlation exists for alcohol consumption in relation to lipoprotein 
particle size (higher alcohol intake is associated with larger low-density 
lipoprotein [LDL] and HDL particles). Yet, a U-shaped association is noted for 
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LDL particle number, whereby those who imbibed 7 to 13 drinks/week had lower 
numbers of LDL particles than nondrinkers or heavy drinkers.71 
 
Light to moderate alcohol consumption has been reported to not protect 
against coronary artery calcium (CAC) accumulation, and although wine 
consumption was neutral for CAC, heavy drinking of distilled spirits or beer was 
associated with higher CAC scores.72 In the Cardiovascular Risk Survey 
comprising 14,618 people, intakes of <4.5 drinks/day were associated with less 
peripheral atherosclerosis, whereas consumption of ≥4.5 drinks/day was 
associated with increased peripheral atherosclerosis.73 
 
In the Pravastatin Inflammation/CRP Evaluation Study, moderate drinkers 
had lower C-reactive protein levels compared to nondrinkers, suggesting that 
light to moderate alcohol intake may be anti-inflammatory.74 Notably, moderate 
alcohol consumption (1 to 2 drinks) improves insulin sensitivity and glucose 
metabolism for the ensuing 12 to 24 hours.75 The biological mechanism whereby 
alcohol improves insulin sensitivity appears to involve suppression of fatty acid 
release from adipose tissue and elevation of adiponectin levels.76,77 Consuming 1 
to 2 drinks/day will lower triglycerides modestly (7%-10%) and decrease 
abdominal obesity.4,78,79    Above 2 drinks/day, abdominal obesity and 
triglycerides increase proportionately with the amount of alcohol consumed.79,80 
 
Red wine is generally high in polyphenols, which have antioxidant, anti-
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inflammatory, and antiplatelet properties.81-83 In fact, small, randomized 
controlled trials have reported red wine improves insulin resistance, lipid profiles, 
and endothelial function compared with other alcoholic beverages.81-83  
 
Potential Cardioprotection Varies Among Different Ethnicities 
 
The health-enhancing association of light or moderate drinking are noted to be 
highly variable among the different races, ethnicities, and cultures.84-86 In the 
landmark NHIS study discussed above, light or moderate drinking was 
associated with lower risk of all-cause mortality in whites but not in blacks;87  
Hispanics appeared to have risk reductions for all-cause and CVD mortality of 
similar magnitude to the benefits noted among whites, though the results were 
less statistically significant due to smaller numbers of study subjects in the 
Hispanic cohort.13 The INTERHEART study,88 a 27,000-patient multi-national 
epidemiological study, reported that regular alcohol consumption was associated 
with risk reduction of MI by 14% with this potential cardioprotection being noted 
in both genders. Subjects from 50 different countries were included in the 
INTERHEART study; of note, the alcohol-related cardioprotection was not 
significant among the cohort from India.88 A study conducted in India comprising 
4,465 participants replicated these findings, whereby those who consumed 
alcohol on a regular basis were observed to have a higher risk of CHD compared 
to nondrinkers.84 Similarly, light and moderate alcohol consumption has not been 
consistently associated with improved health outcomes in Chinese 
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populations.89,90 
 
Healthy vs Dangerous Drinking Patterns 
 
The health benefits linked to drinking, similar to those conferred by exercise,91 
are most likely to be manifest when done daily and in moderation.7,91 This is 
probably because a significant proportion of the benefits seen with light to 
moderate drinking are temporary—typically disappearing within 24 hours.7  
 
The consensus scientific definition of light to moderate alcohol 
consumption is not more than 1 drink/day for women and not more than 2 
drinks/day for men. Among the various alcoholic beverages, red wine, likely due 
to it being intrinsically rich in antioxidant compounds and generally low in sugar, 
may be the optimal choice from a health perspective.18,81,82,92-94 However, the 
data is probably not strong enough to suggest red wine to people who prefer 
other alcoholic beverages. Binge drinking, typically defined as ≥5 drinks within a 
few hours, often with intoxication as an intended consequence, is linked to 
adverse health outcomes including a doubling of risk of mortality.95,96  Even 
occasional binges diminish the protection associated with an otherwise light to 
moderate drinking pattern.3 Moreover, heavy drinking often triggers disruptive 
and destructive social forces, such as depression, isolation, abuse and 
violence.4,97  
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Light to moderate alcohol consumption was identified as the single 
strongest correlate for predicting improved life expectancy noted among followers 
of the traditional Mediterranean diet.97 In this study moderate alcohol 
consumption accounted for 25% of the longevity boost associated with lifelong 
adherence to the Mediterranean cuisine; other longevity-boosting factors were 
vegetable, fruit and nut consumption, olive oil use, and fish intake, but none 
appeared to be as strongly correlated as alcohol.  
 
Cultures with exceptional longevity, such as societies adhering to the 
traditional Mediterranean diet, often incorporate light or moderate alcohol 
consumption before or during the largest meal of the day.97,98 The potential 
advantages of drinking at dinnertime could be due to effectiveness of low to 
moderate doses of ethanol for blunting postprandial glucose spikes and 
associated inflammation,99  and/or the potential pro-social association of light to 
moderate drinking, which could enhance emotional bonding and foster 
interpersonal connection. Notably, smoking tobacco appears to completely 
neutralize the potential cardioprotection otherwise afforded by light or moderate 
drinking.13 
 
Caveats  
For women, even light to moderate alcohol intake is associated with increased 
risk for breast cancer.100,101 Recent studies show that chronic heavy alcohol use 
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adversely affects brain structure and function, with problem drinking causing 
atrophy of the hippocampus and cerebellum.102 Even moderate alcohol intake 
(>2 drinks/day) is associated with increased risk of adverse brain changes 
(particularly in the hippocampal memory regions) and steeper age-related 
cognitive decline in verbal fluency.103 In this recent study, no protective effect on 
brain structure or cognition was noted for light drinking compared to 
abstinence.103 
The Atherosclerosis Risk in Communities (ARIC) study reported that 
among nondrinkers who are deemed by their physician to be at low risk for 
addiction, initiation of light or moderate alcohol intake was reasonably safe.104 
Yet, other studies report that it is very difficult to consistently predict individuals 
who might be at increased risk for problem drinking once they begin to consume 
alcohol on a regular basis.4,5,7 In fact, habitual alcohol consumption seems to be 
a “slippery slope” that cannot be safely navigated by a substantial portion of the 
population. For this reason the American Heart Association recommends that 
nondrinkers should not be advised to start drinking.105 Moreover, an estimated 
5% of US adults meet diagnostic criteria for alcohol abuse; only 1 in 10 of these 
problem drinkers will seek and receive formal treatment, usually with 
dishearteningly low rates of chronic ethanol abstinence.90 As of January 2018, a 
new clinical trial was initiated by Mukamal, “Moderate Alcohol and 
Cardiovascular Health (MACH15)”.  This long term randomized trial will compare 
the effects of 1 standard serving (approximately 15 grams) of alcohol daily versus 
abstention for individuals aged 50 years and older with advanced CVD.106  
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Conclusion:  
Alcohol consumption is a double-edged sword that can cut deeply in either 
direction—potentially beneficial to health and wellbeing in small doses, but toxic 
and potentially lethal in larger doses. Individuals who customarily consume 
alcohol should typically limit their daily intake to not more than 1 drink/day for 
women and not more than 2 drinks/day for men. Health care providers should not 
advise nondrinkers to begin drinking. Problem drinkers should be advised to 
abstain permanently and seek professional help to attain this.  
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Figure Legend 
 
 
Fig 1 - Alcohol intake and total mortality. Data from Arch Intern Med.11 
 
 
Fig 2 - Adjusted risks for cardiovascular (CV) disease as a function of alcohol 
intake. CHD = coronary heart disease; HR = hazard ratio. Error bars indicate 
95% CIs. Data from Journal of the American College of Cardiology.12 
 
Fig 3 – With median follow-up was 8.2 years, compared with lifetime abstainers, 
individuals who were light or moderate drinkers were at a lowered risk of all-
cause mortality, but that risk increased significantly with heavy alcohol 
consumption, as seen in this J-shaped curve. HR = hazard ratio. Blue lines = 
95% confidence interval.13  
Fig 4 - Alcohol consumption and risk of CV disease (CVD) mortality.13  
 
Fig 5 - Alcohol consumption and risk of cancer mortality.13 
 
Fig 6 - Dose-response relationship between alcohol consumption and risk of 
atrial fibrillation (AF). At 10 drinks/day, the risk of AF is doubled. Confidence 
interval (CI) is marked by dashes.28 Adapted from European Journal of 
Cardiovascular Prevention and Rehabilitation used with permission. 
 
Fig 7 - The American Stroke Association guidelines advise that heavy drinkers 
who have suffered an ischemic stroke or transient ischemic attack should 
eliminate or reduce their alcohol consumption. These guidelines also defined 
“reasonable” alcohol intake as not more than 2 drinks/day for males and 1 
drink/day for females.53 
 
Fig 8 - Associations between alcoholic beverage consumption and development 
of new T2D for: (a) wine, (b) beer, and (c) distilled spirits.60  
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